NF-κB

NF-κB. It is a pivotal transcription factor complex found in nearly all animal cells and is a central regulator of the immune response. Its discovery is closely tied to research on the immunoglobulin kappa light chain in B cells. Dysregulation of its activity is a hallmark of many diseases, including inflammatory diseases, autoimmune diseases, and various cancers.

Structure and Function

The complex is composed of proteins from the Rel homology domain family, which includes RelA, RelB, and c-Rel, as well as the precursor proteins NF-κB1 and NF-κB2. These subunits form various homodimer and heterodimer combinations, with the most common being a RelA-p50 heterodimer. The DNA-binding domain within the Rel homology domain allows it to bind to specific κB site sequences in the promoters and enhancers of target genes. This binding initiates the transcription of a vast array of genes involved in cell survival, proliferation, and the immune system.

Activation

Activation primarily occurs via the canonical pathway and the non-canonical pathway. The canonical pathway is rapidly triggered by signals such as tumor necrosis factor (TNF), interleukin-1 (IL-1), and pathogen-associated molecular patterns (PAMPs) detected by Toll-like receptors. This leads to the activation of the IκB kinase (IKK) complex, which phosphorylates the inhibitor IκBα, targeting it for ubiquitin-mediated proteasomal degradation. The non-canonical pathway, activated by signals like lymphotoxin beta and B cell activating factor (BAFF), involves the NF-κB-inducing kinase (NIK) and results in the processing of p100 to p52.

Role in Immune Response

It is essential for both the innate immune system and the adaptive immune system. In the innate immune system, it drives the production of pro-inflammatory cytokines, chemokines, and adhesion molecules in cells like macrophages and dendritic cells. For the adaptive immune system, it is critical for lymphocyte development and activation; in B cells, it regulates immunoglobulin production, and in T cells, it is involved in T cell receptor signaling and the expression of interleukin-2.

Role in Inflammation

It is a master regulator of the inflammatory response. Upon activation, it induces the expression of key mediators such as cyclooxygenase-2 (COX-2), inducible nitric oxide synthase (iNOS), and cytokines including interleukin-6 (IL-6) and interleukin-8 (IL-8). Chronic, dysregulated activity contributes to the pathogenesis of numerous inflammatory diseases, such as rheumatoid arthritis, inflammatory bowel disease, and atherosclerosis.

Clinical Significance

Its pathway is a major therapeutic target. Persistent activation is implicated in the development and progression of many cancers, including lymphomas and breast cancer, by promoting cell proliferation and inhibiting apoptosis. In autoimmune diseases like lupus and multiple sclerosis, its hyperactivity drives inappropriate immune attacks. Drugs such as glucocorticoids and more specific agents like bortezomib and sulfasalazine work, in part, by inhibiting various components of the pathway.

Regulation

Tight regulation is achieved through multiple mechanisms. The primary regulators are the IκB family of inhibitor proteins, which sequester the complex in the cytoplasm. Post-translational modifications, including phosphorylation, acetylation, and ubiquitination, finely tune its activity, nuclear translocation, and DNA-binding affinity. Negative feedback loops are also crucial; for instance, the RelA-p50 dimer can induce the transcription of IκBα, which rapidly re-inhibits the complex, restoring homeostasis.